From: Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature
Hereditary breast and ovarian cancer syndrome
 BRCA1
 BRCA2
Fanconi anemia pathway
 RAD51C
 RAD51D
 RAD50
 BRIP1
 BARD1
 CHEK2
 MRE11A
 NBN
 PALB2
Mismatch repair
 MLH1
 MSH2
 MSH6
 PMS2
Other
 TP53